Belhaven Biopharma

About:

Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing.

Top Investors: North Carolina Biotechnology Center

Description:

Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing, and a pilot human clinical trial for its dry powder intranasal epinephrine for treatment of anaphylaxis

Total Funding Amount:

$750000

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

2021-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2023-02-16

IPO Status:

Private

Industries: